Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
대표청구항▼
1. An intragastric balloon comprising: an initial fill gas, consisting of nitrogen and one or more inert gases selected from the group consisting of SF6, C2F6, C3F8, C4F10, C4F8, C3F6, CF4, and C(ClF2)—CF3;a valve system configured for introducing the initial fill gas into the balloon in vivo; anda
1. An intragastric balloon comprising: an initial fill gas, consisting of nitrogen and one or more inert gases selected from the group consisting of SF6, C2F6, C3F8, C4F10, C4F8, C3F6, CF4, and C(ClF2)—CF3;a valve system configured for introducing the initial fill gas into the balloon in vivo; anda polymeric wall comprising one or more layers, wherein the polymeric wall is configured to have, under in vivo conditions, a permeability to CO2 of more than 10 cc/m2/day, and wherein the polymeric wall is configured such that, in vivo, the balloon is configured to gain in volume and in pressure during a useful life of the intragastric balloon when filled with the initial fill gas,wherein the intragastric balloon when inflated with the initial fill as is ellipsoid with a nominal radius of from 2.5 cm to 7.6 cm, a nominal height of from 0.6 cm to 7.6 cm, a volume of from 90 cm3 to 350 cm3 at 37° C., an internal nominal pressure at 37° C. of 0 Pa to 103421 Pa, and a weight of less than 15 g. 2. The intragastric balloon of claim 1, wherein the polymeric wall comprises a three layer CO2 barrier material consisting of nylon/polyvinylidene chloride/polyethylene. 3. The intragastric balloon of claim 1, wherein the polymeric wall comprises a three layer CO2 barrier material consisting of nylon/ethylene vinyl alcohol/polyethylene. 4. The intragastric balloon of claim 1, wherein the polymeric wall comprises a two layer CO2 barrier material consisting of nylon/polyethylene and no additional CO2 barrier material. 5. The intragastric balloon of claim 1, wherein the polymeric wall comprises a four layer CO2 barrier material consisting of nylon/ethylene vinyl alcohol/polyvinylchloride/polyethylene. 6. The intragastric balloon of claim 1, wherein the polymeric wall comprises a nylon layer, a polyvinylidene chloride layer, and a polyethylene layer. 7. The intragastric balloon of claim 1, wherein the polymeric wall comprises a nylon layer, a polyvinylidene chloride layer, a polyethylene layer, and an ethylene vinyl alcohol layer. 8. The intragastric balloon of claim 1, wherein the polymeric wall comprises a nylon layer, a polyethylene layer, and an ethylene vinyl alcohol layer. 9. The intragastric balloon of claim 1, wherein the inert gas initial fill gas consists of nitrogen and SF6. 10. The intragastric balloon of claim 1, wherein the intragastric balloon is configured to have a useful life in an in vivo gastric environment of at least 30 days and wherein the balloon wins from 5 to 300% in volume during the useful life of the intragastric balloon when filled with the initial fill gas. 11. A method for inflating an intragastric balloon, comprising: providing an intragastric balloon comprising a valve system and a polymeric wall, wherein the polymeric wall comprises one or more layers, and wherein the polymeric wall is configured to have, under in vivo conditions, a permeability to CO2 of more than 10 cc/m2/day;introducing, in an in vivo intragastric environment, an initial fill gas consisting of nitrogen and one or more inert gases selected from the group consisting of SF6, C2F6, C3F8, C4F10, C4F8, C3F6, CF4, and C(ClF2)—CF3 into the intragastric balloon through the valve system so as to fill the intragastric balloon, wherein the filled balloon is ellipsoid with a nominal radius of from 2.5 cm to 7.6 cm, a nominal height of from 0.6 cm to 7.6 cm, an initial volume of from 90 cm3 to 350 cm3 at 37° C., an internal nominal pressure at 37° C. of 0 Pa to 103421 Pa, and a weight of less than 15 g; andexposing the filled balloon to the in vivo intragastric environment for a useful life of the intragastric balloon, whereby the initial fill gas diffuses through the polymeric wall and into the in vivo intragastric environment, and whereby gases in the in vivo intragastric environment diffuse into the balloon through the wall, whereby the intragastric balloon gains in volume and in pressure over the useful life. 12. The method of claim 11, wherein the polymeric wall comprises a three layer CO2 barrier material consisting of nylon/polyvinylidene chloride/polyethylene. 13. The method of claim 11, wherein the polymeric wall comprises a three layer CO2 barrier material consisting of nylon/ethylene vinyl alcohol/polyethylene. 14. The method of claim 11, wherein the polymeric wall comprises a two layer CO2 barrier material consisting of nylon/polyethylene and no additional CO2 barrier material. 15. The method of claim 11, wherein the polymeric wall comprises a four layer CO2 barrier material consisting of nylon/ethylene vinyl alcohol/polyvinylchloride/polyethylene. 16. The method of claim 11, wherein the polymeric wall comprises a nylon layer, a polyvinylidene chloride layer, and a polyethylene layer. 17. The method of claim 11, wherein the polymeric wall comprises a nylon layer, a polyvinylidene chloride layer, a polyethylene layer, and an ethylene vinyl alcohol layer. 18. The method of claim 11, wherein the polymeric wall comprises a nylon layer, a polyethylene layer, and an ethylene vinyl alcohol layer. 19. The method of claim 11, wherein the initial fill gas consists essentially of nitrogen and SF6. 20. The method of claim 11, wherein the intragastric balloon is configured to have a useful life in an in vivo gastric environment of at least 30 days, and wherein the balloon gains from 5 to 300% in volume during the useful life of the intragastric balloon when filled with the initial fill gas.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (54)
Kullas Karen E. (Taunton MA) Giusto Joseph (Warren RI), Anti-obesity balloon placement system.
Imran, Mir; Herrmann, Peter; Syed, Baber; Williams, Timothy H.; Ong, Chang Jin; Method, Greg, Device, system and methods for the oral delivery of therapeutic compounds.
Matsuura, David G.; Gillespie, Walter D.; Wallin, Sheila K.; Connors, Kevin G.; Bullister, Edward, Devices and methods for attenuation of pressure waves in the body.
Lewkowicz,Shlomo; Gat,Daniel; Glukhovsky,Arkady; Khait,Semion; Iddan,Gavriel Joseph; Jacob,Harold; Swain,Christopher Paul, Floatable in vivo sensing device and method for use.
Yamamoto Taizo (Osaka JPX) Abe Kenji (Nara JPX) Matsuura Seinosuke (Souraku JPX), Hard capsule for pharmaceutical drugs and method for producing the same.
Weiner Brian C. (24 Bowling Green Pl. Staten Island NY 10314) Weiner Sarah H. (24 Bowling Green Pl. Staten Island NY 10314), Inflatable gastric device for treating obesity and method of using the same.
Gau Fred C. (14812 Imperial Dr. Libertyville IL 60048) Hancock John C. (449 Paseo del Descanso Santa Barbara CA 93105), Intragastric balloon with improved valve locating means.
Brister, Mark C.; Quintana, Nelson; Patel, Kaushik A.; Drake, Neil R.; Llevares, Antonio C.; Markovic, Dubravka; Rasdal, Andrew P.; VandenBerg, Amy D. L., Intragastric device.
Brister, Mark C.; Quintana, Nelson; Patel, Kaushik A; Drake, Neil R.; Llevares, Antonio C.; Markovic, Dubravka; Rasdal, Andrew P.; VandenBerg, Amy D. L., Intragastric device.
Brister, Mark C.; Rasdal, Andrew P.; Drake, Neil R.; Lake, Matthew S.; Markovic, Dubravka; VandenBerg, Amy D. L.; Llevares, Antonio C.; Nider, Josefina, Intragastric device.
Brister, Mark C.; Rasdal, Andrew P.; Drake, Neil R.; Lake, Matthew S.; Markovic, Dubravka; VandenBerg, Amy D. L.; Llevares, Antonio C.; Nider, Josefina, Intragastric device.
Berman Edward J. (3426 N. Meridian Indianapolis IN 46208) Rowe George A. (3426 N. Meridian Indianapolis IN 46208), Method and apparatus for reducing obesity.
Smith Jeffrey A. ; Wallace Daniel T. ; Hlavka Edwin J. ; Gresl Charles ; Lunsford John P. ; Chin Albert K., Method and inflatable chamber apparatus for separating layers of tissue.
Kim Sunyong (105 Valley Forge St. Charles MO 63303) Lee Dae W. (1575 N. Warson Rd. St. Louis MO 63132), Self-contained, self-inflating novelty balloon.
Imran, Mir, Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device.
Imran, Mir, Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.